Target intelligence / Profile preview

Systemic paracrine and immunomodulatory milieu

Molecular classification
Other
01

Overview

The systemic paracrine and immunomodulatory milieu refers to the complex, dynamic network of secreted signaling molecules—including cytokines, chemokines, growth factors, and extracellular vesicles—that collectively regulate immune cell activity and tissue homeostasis across the body (Caplan, 2017; Pittenger et al., 2019). This term does not describe a single molecular entity but rather the integrated biochemical environment that dictates the nature of the immune response, whether pro-inflammatory or anti-inflammatory. In many disease states, such as sepsis, autoimmune disorders, and cancer, this milieu becomes dysregulated, leading to chronic inflammation or immune evasion. Therapeutic interventions like mesenchymal stem cell (MSC) therapy or broad-spectrum immunomodulators aim to reprogram this environment to favor tissue repair and immune resolution (Galipeau & Sensébé, 2018). Consequently, monitoring the components of this milieu is vital for assessing disease progression and the efficacy of systemic therapies. This holistic approach to immunomodulation addresses the synergistic effects of multiple signaling pathways rather than isolated molecular targets.

Other names
Immunomodulatory environmentParacrine signaling networkSecretome-mediated milieuSystemic inflammatory environment
02

Mechanism of action

Modulation of the collective signaling environment through the secretion or inhibition of multiple cytokines, chemokines, and growth factors to restore immune homeostasis (Galipeau & Sensébé, 2018; Pittenger et al., 2019).

03

Biological functions

Immune responseSignal transductionCell-to-cell communicationTissue repairInflammation regulation
04

Disease associations

InflammationAutoimmune diseaseCancerSepsisGraft-versus-host disease
05

Safety considerations

Systemic immunosuppressionCytokine release syndromeImpaired wound healingIncreased susceptibility to infectionPotential for tumor promotion
06

Interacting drugs

Mesenchymal stem cells

5 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Interleukin-10 (IL-10)C-reactive protein (CRP)Interferon-gamma (IFN-gamma)Soluble HLA-G

Beyond the preview

Go deeper on Systemic paracrine and immunomodulatory milieu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic paracrine and immunomodulatory milieu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call